13 reports

The patent deals with invention relates to methods for the production of a recombinant protein in a mammalian cell and methods to enhance the production of recombinant proteins in mammalian cells.

  • Blood Disease
  • Gene Therapy
  • Recombinant Protein
  • Therapy
  • Supply

Recombinant Protein..............

  • Recombinant Protein
  • Vaccine
  • Europe
  • World
  • Market Size

China Recombinant Protein Drug Industry Report, 2014-2017 ##.

  • Insulin
  • Recombinant Protein
  • Therapy
  • China
  • Forecast

##. ## Recombinant Proteins Overview ##. ## History of Recombinant Proteins ##.

  • Biopharmaceutical
  • Recombinant Protein
  • World
  • Market Size
  • Recombinant Protein for Multiple Sclerosis
  • Recombinant Protein for Allergy
  • Recombinant Protein
  • Research And Development
  • World
  • Product Initiative
  • Toleranzia AB
  • RECOMBINANT PROTEIN 2 FOR CANCER
  • RECOMBINANT PROTEIN 1 FOR CANCER
  • Recombinant Protein
  • China
  • World
  • Product Initiative
  • LegoChem Biosciences, Inc
  • Recombinant Proteins 4 for Opthalmology
  • Recombinant Protein 1 for Cancer
  • Recombinant Protein
  • Therapy
  • World
  • Product Initiative
  • Molecular Partners AG
  • RECOMBINANT PROTEIN FOR OSTEOPOROSIS - DRUG PROFILE
  • RECOMBINANT PROTEIN TO AGONIZE PTH RECEPTOR FOR OSTEOPOROSIS AND OSTEOARTHRITIS
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Recombinant Protein
  • Research And Development
  • Amgen Inc.
  • Recombinant Proteins to Inhibit IGF-2 for Oncology
  • RECOMBINANT PROTEINS TO INHIBIT IGF-2 FOR ONCOLOGY - DRUG PROFILE
  • Biopharmaceutical
  • Recombinant Protein
  • United States
  • World
  • Product Initiative
  • Ipsen S.A. - Pipeline by Molecule Type, 2016

A. is developing recombinant protein (rBoNT) for the treatment of movement disorders.

  • Recombinant Protein
  • Therapy
  • World
  • Product Initiative
  • Ipsen S.A.
  • RECOMBINANT PROTEIN TO ANTAGONIZE IGF-1R FOR ONCOLOGY - DRUG PROFILE
  • RECOMBINANT PROTEINS TO AGONIZE IGF-1R FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • Chemotherapy
  • Hospital
  • Recombinant Protein
  • United States
  • Product Initiative
  • Recombinant Protein for Prostate Cancer
  • Recombinant Protein for Cancer
  • Infectious Disease
  • Recombinant Protein
  • Research And Development
  • Therapy
  • Immunocore Limited
  • RECOMBINANT PROTEINS TO AGONIZE IGF-1R FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • RECOMBINANT PROTEIN TO AGONIZE IGF-1 RECEPTOR FOR OSTEOARTHRITIS - DRUG PROFILE
  • Lung Cancer
  • Pharmaceutical
  • Recombinant Protein
  • United States
  • Product Initiative